Form CORRESP - Correspondence:
SEC Accession No. 0001171843-16-009165
Filing Date
2016-04-14
Accepted
2016-04-14 16:00:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7481
  Complete submission text file 0001171843-16-009165.txt   8410
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)